1. Home
  2. SNY vs GSL Comparison

SNY vs GSL Comparison

Compare SNY & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • GSL
  • Stock Information
  • Founded
  • SNY 1994
  • GSL 2007
  • Country
  • SNY France
  • GSL Greece
  • Employees
  • SNY N/A
  • GSL N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • GSL Marine Transportation
  • Sector
  • SNY Health Care
  • GSL Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • GSL Nasdaq
  • Market Cap
  • SNY 123.6B
  • GSL 758.7M
  • IPO Year
  • SNY N/A
  • GSL 2006
  • Fundamental
  • Price
  • SNY $50.25
  • GSL $21.99
  • Analyst Decision
  • SNY Buy
  • GSL Strong Buy
  • Analyst Count
  • SNY 2
  • GSL 1
  • Target Price
  • SNY $62.50
  • GSL $29.00
  • AVG Volume (30 Days)
  • SNY 3.1M
  • GSL 280.7K
  • Earning Date
  • SNY 04-24-2025
  • GSL 05-19-2025
  • Dividend Yield
  • SNY 3.09%
  • GSL 8.20%
  • EPS Growth
  • SNY 39.56
  • GSL 17.78
  • EPS
  • SNY 5.45
  • GSL 9.67
  • Revenue
  • SNY $48,817,552,946.00
  • GSL $705,529,000.00
  • Revenue This Year
  • SNY $5.35
  • GSL $1.84
  • Revenue Next Year
  • SNY $6.69
  • GSL N/A
  • P/E Ratio
  • SNY $9.56
  • GSL $2.22
  • Revenue Growth
  • SNY N/A
  • GSL 5.82
  • 52 Week Low
  • SNY $45.80
  • GSL $17.73
  • 52 Week High
  • SNY $60.12
  • GSL $30.32
  • Technical
  • Relative Strength Index (RSI)
  • SNY 39.23
  • GSL 57.54
  • Support Level
  • SNY $51.67
  • GSL $21.26
  • Resistance Level
  • SNY $55.73
  • GSL $22.23
  • Average True Range (ATR)
  • SNY 0.88
  • GSL 0.47
  • MACD
  • SNY -0.09
  • GSL 0.18
  • Stochastic Oscillator
  • SNY 7.84
  • GSL 92.28

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About GSL Global Ship Lease Inc New

Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.

Share on Social Networks: